Mankind Pharma emblem. File
| Photograph Credit score: Reuters
Mankind Pharma Ltd. mentioned it had obtained regulatory approvals together with the approval from the Competitors Fee of India for 100% acquisition of Bharat Serums and Vaccines Ltd. (BSV).
“The Proposed Transaction is topic to completion of remaining customary situations precedent as contemplated within the Share Buy Agreements,” the corporate mentioned in a submitting with exchanges.
The corporate hadannounced the execution of the Share Buy Settlement dated July 25, 2024, amongst the corporate, BSV and the sellers Ansamira Ltd. and Miransa Ltd., (associates of funds managed by Introduction Worldwide), and sure minority shareholders i.e. Bhaskar Iyer and Abhijit Mukherjee for the proposed acquisition of 100% stake in BSV for ₹13,630 crore.
Printed – October 02, 2024 11:03 pm IST
